Stocks · Healthcare · Biotechnology
Vanda Pharmaceuticals Inc. VNDA
$4.58 -1.08% Close, Oct 5, 2026 · NASDAQ · Market cap $278.4M
Weak trendLow risk
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin narrowed to -86.1% from -51.3% a year earlier.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
- The stock is 52% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 42%
- Revenue growth, 3-year CAGRBottom 15%
- Revenue growth accelerationBottom 35%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 16%
- Gross marginTop 16%
- Operating marginBottom 30%
- Accruals (lower is better)Top 14%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 6%
- Free-cash-flow yieldBottom 5%
- EBITDA / enterprise valueBottom 7%
- Sales / enterprise valueTop 11%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 39%
- 6-month returnBottom 13%
- 1-year return vs S&P 500Bottom 34%
- Distance from 52-week highBottom 23%
- Trend checklist (0–4)Bottom 13%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 15%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 37%
- Upside to consensus price targetTop 15%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 20%
- Maximum drawdown, 3 yearsTop 25%
- Beta vs S&P 500 (lower is better)Top 22%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 8.2% | 6.0% | ↓ |
| Gross margin | 93.5% | 92.8% | ↓ |
| Operating margin | -51.3% | -86.1% | ↓ |
| FCF margin | -32.4% | -89.7% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 6.0% | 8.2% | ↓ | Bottom 42% |
| Gross margin | 92.8% | 93.5% | ↓ | Top 16% |
| Operating margin | -86.1% | -51.3% | ↓ | Bottom 30% |
| Net margin | -127.4% | -32.9% | ↓ | — |
| Free-cash-flow margin | -89.7% | -32.4% | ↓ | — |
| Return on invested capital | -73.4% | — | Bottom 16% | |
| Revenue growth, 3-year CAGR | -5.3% | — | Bottom 15% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -20.0%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 5.4%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +26.6 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 0.00%
- Shareholder yield
- 0.00%
- Share count change, 1 year
- +2.1%
- Share count change, 3-year CAGR
- +1.5%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- -41.4%
- Average 2-day reaction, last 8
- -1.8%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $15.50
- Target vs current price
- +238.4%
- Analysts with a rating
- 19
- Share rating Buy or Strong Buy
- 68%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | -78.5% | -4.5% | -7.5% | +1.7% | — |
| May 6, 2026 | -54.7% | +0.7% | -13.1% | -17.6% | -31.0% |
| Feb 11, 2026 | -9.6% | +0.1% | -18.7% | +25.2% | -13.9% |
| Oct 29, 2025 | -22.6% | -3.0% | -22.0% | -10.4% | +39.4% |
| Jul 31, 2025 | -35.3% | -8.8% | -9.6% | -1.1% | +17.6% |
| May 7, 2025 | +9.1% | +0.2% | -8.9% | +1.6% | -4.1% |
| Feb 13, 2025 | +42.9% | -1.1% | -5.5% | +3.6% | -16.8% |
| Nov 6, 2024 | +47.1% | +2.1% | +12.7% | +1.0% | -6.5% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | -$1.04 | -$0.58 | -78.5% | $50.5M |
| May 6, 2026 | -$0.82 | -$0.53 | -54.7% | $51.7M |
| Feb 11, 2026 | -$2.39 | -$2.18 | -9.6% | $57.2M |
| Oct 29, 2025 | -$0.38 | -$0.31 | -22.6% | $56.3M |
| Jul 31, 2025 | -$0.46 | -$0.34 | -35.3% | $52.6M |
| May 7, 2025 | -$0.50 | -$0.55 | +9.1% | $50.0M |
| Feb 13, 2025 | -$0.08 | -$0.14 | +42.9% | $53.2M |
| Nov 6, 2024 | -$0.09 | -$0.17 | +47.1% | $47.7M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 1.14× | — | — | Top 11% |
| Free-cash-flow yield | -69.48% | — | — | Bottom 5% |
| Earnings yield | -101.09% | — | — | Bottom 6% |
P/E over the past five years
Range 16.5× – 93.1× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -6.2%
- 200-day average slope (20 days)
- -0.8%
- Distance from 50-day average
- -11.4%
- Distance from 200-day average
- -29.8%
- RSI (14)
- 31.7
- Relative volume
- 0.68×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 39.3%
- Volatility vs own 5-year history
- 22th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.62
- Correlation with S&P 500
- 0.15
- Current drawdown from 1-year high
- -52.1%
- Maximum drawdown, 3 years
- -52.1%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jun 30, 2021 | Nov 9, 2023 | -84.3% | 595 days | Not yet recovered |
| Feb 24, 2021 | Mar 30, 2021 | -26.6% | 24 days | 61 days (Jun 25, 2021) |
| Oct 12, 2020 | Oct 21, 2020 | -10.4% | 7 days | 9 days (Nov 3, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $278.4M
- EPS, diluted (TTM)
- -$4.63
- Revenue (TTM)
- $215.7M
- 52-week range
- $4.27 – $9.94
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $268.7M | $254.4M | $192.6M | $198.8M | $216.1M |
| Gross profit | $243.1M | $230.1M | $177.8M | $187.5M | $203.1M |
| Operating income | $42.2M | $6.3M | -$14.0M | -$40.7M | -$151.2M |
| Net income | $33.2M | $6.3M | $2.5M | -$18.9M | -$220.5M |
| EPS (diluted) | $0.58 | $0.11 | $0.04 | -$0.32 | -$3.74 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $47.7M | $53.2M | $50.0M | $52.6M | $56.3M | $57.2M | $51.7M | $50.5M |
| Net income | -$5.3M | -$4.9M | -$29.5M | -$27.2M | -$22.6M | -$141.2M | -$48.6M | -$62.5M |
| EPS (diluted) | -$0.09 | -$0.08 | -$0.50 | -$0.46 | -$0.38 | -$2.39 | -$0.82 | -$1.04 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $64.2M | $32.0M | $12.8M | -$15.8M | -$109.4M |
| Capital expenditure | -$552,000 | -$679,000 | -$383,000 | -$490,000 | -$998,000 |
| Free cash flow | $63.7M | $31.3M | $12.4M | -$16.2M | -$110.4M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $3.5M | $734,000 | $0 | $0 | $0 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $170.0M
- Total assets
- $412.5M
- Total liabilities
- $192.3M
- Total debt
- $22.8M
- Net debt
- -$33.0M
- Shareholders’ equity
- $220.2M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 8,495,290
- Days to cover
- 12.07
- Change vs previous report
- +10.5%
FINRA short interest, settlement date Sep 15, 2026.